Use este identificador para citar ou linkar para este item: http://hdl.handle.net/1843/55781
Tipo: Artigo de Periódico
Título: Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)
Autor(es): Nicolas j Muller
Oriol Manuel
Hande Arslan
Imran Hasanoglu
Maria López Oliva
Sheila Chiese
Nicola Duccio Salerno
Olivier Lortholary
Mical Paul
Anne Scemla
Elisa Grazia Calvi
Laurent Dewispelaere
Paulo Henrique Orlandi Mourão
Athina Pyrpasopoulou
Iordanis Romiopoulos
Elias Iosifidis
Edson Abdala
Marta Bodro
Tania Mara Varejão Strabelli
Noa Cohen'sinai
María Carmen Fariñas
Warren Lowman
Marco Falcone
Esra Kazak
Mario Tumbarello
Erika Lease
Nina Nestorova
Ligia C.pierrotti
Francisco López'medrano
Rafael San'juan
Miguel Montejo
Maristela p. Freire
Elisa Cordero
Miruna d. David
Esperanza Merino
Seema Mehta Steinke
Paolo a. Grossi
Ángela Cano
Elena Pérez'nadales
Elena m. Seminari
Maricela Valerio
Filiz Gunseren
Meenakshi Rana
Alessandra Mularoni
Pilar Martín'dávila
Christian Delden
Melike Hamiyet Demirkaya
Zeliha Koçak Tufan
Belén Loeches
Mario Fernández'ruiz
Ranganathan n. Iyer
Fabio Soldani
Britt'marie Eriksson
Benoît Pilmis
Marco Rizzi
Julien Coussement
Wanessa Trindade Clemente
Emmanuel Roilides
Álvaro Pascual
Luis Martínez'martínez
Belén Gutiérrez'gutiérrez
Jesús Rodríguez'baño
Julian Torre'cisneros
José María Aguado
Terence yi Shern Kee
Núria Sabé
Mariana Camoez
María a Domínguez
Fidi Koppel
Jaime Lora'tamayo
Leyre Lopez'soria
Ban Hock Tan
Elias David'neto
Flávio Jota de Paula e Flávia Rossi
Jose Antonio Lepe
Gabriel Bernal Blanco
Cecilia Martín'gandul
Noelia Balibrea
Antonio Franco
Robin Avery
Darin Ostrander
Daniela Dalla Gasperina
Jordi Carratalà
Cristina Rovelli
Alejandra m Natera
Manuel Recio'rufián
Julia Guzmán'puche
Cristina Leoni
Patricia Muñoz
Carlos Sánchez'carrillo
Sara Lardo
Deena Rose Altman
Jesús Fortún
Isabel Oriol
Rosa Escudero
Francesca Gioia
Resumo: Background: Whether active therapy with β-lactam/β-lactamase inhibitors (BLBLI) is as affective as carbapenems for extended spectrum β-lactamase-producing Enterobacterales (ESBL-E) bloodstream infection (BSI) secondary to urinary tract infection (UTI )in kidney transplant recipients (KTRs) remains unclear.Methods: We retrospectively evaluated 306 KTR admitted to 30 centers from January 2014 to October 2016. Therapeutic failure (lack of cure or clinical improvement and/or death from any cause) at days 7 and 30 from ESBL-E BSI onset was the primary and secondary study outcomes, respectively.Results: Therapeutic failure at days 7 and 30 occurred in 8.2% (25/306) and 13.4% (41/306) of patients. Hospital-acquired BSI (adjusted OR [aOR]: 4.10; 95% confidence interval [CI]: 1.50-11.20) and Pitt score (aOR: 1.47; 95% CI: 1.21-1.77) were independently associated with therapeutic failure at day 7. Age-adjusted Charlson Index (aOR: 1.25; 95% CI: 1.05-1.48), Pitt score (aOR: 1.72; 95% CI: 1.35-2.17), and lymphocyte count ≤500 cells/μL at presentation (aOR: 3.16; 95% CI: 1.42-7.06) predicted therapeutic failure at day 30. Carbapenem monotherapy (68.6%, primarily meropenem) was the most frequent active therapy, followed by BLBLI monotherapy (10.8%mostly piperacillin-tazobactam). Propensity score (PS)-adjusted models revealed no significant impact of the choice of active therapy (carbapenem-containing vs any other regimen, BLBLI- vs carbapenem-based monotherapy) within the first 72 hours on any of the study outcomes. Conclusions: Our data suggest that active therapy based on BLBLI may be as effective as carbapenem-containing regimens for ESBL-E BSI secondary to UTI in the specific population of KTR. Potential residual confounding and unpowered sample size cannot be excluded (ClinicalTrials.gov identifier: NCT02852902).
Assunto: Sepse
Transplante de rim
Resultado de tratamento
Infecções Urinárias
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Instituição: UFMG
Departamento: MED - DEPARTAMENTO DE PROPEDÊUTICA COMPLEMENTAR
Tipo de Acesso: Acesso Restrito
Identificador DOI: 10.1111/tid.13520
URI: http://hdl.handle.net/1843/55781
Data do documento: 2021
metadata.dc.url.externa: https://onlinelibrary.wiley.com/doi/10.1111/tid.13520
metadata.dc.relation.ispartof: Transplant Infectious Disease
Aparece nas coleções:Artigo de Periódico

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.